Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VVANDA PHARMACEUTICALS INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

VANDA PHARMACEUTICALS INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $50.53M. Net result −$62.51M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $50.53M. Running result $50.53M. Fanapt: $35.99M. Hetlioz: $5.58M. NEREUS: $1.03M. PONVORY: $7.94M.
  • Cost of revenue: −$3.56M. Running result $46.97M.
  • Gross profit: $46.97M. Running result $46.97M.
  • Research and development: −$36.95M. Running result $10.02M.
  • Selling, general and administrative: −$71.84M. Running result −$61.82M.
  • Intangible asset amortization: −$1.99M. Running result −$63.81M.
  • Operating income: −$63.81M. Running result −$63.81M.
  • Other income: $1.43M. Running result −$62.38M.
  • Pre-tax loss: −$62.38M. Running result −$62.38M.
  • Income tax expense: −$129K. Running result −$62.51M.
  • Net loss: −$62.51M. Running result −$62.51M.